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Abstract
Background: There is a general notion that stressful life 
events may cause mental and physical health problems. Ob-
jectives: We aimed to describe stressful life events reported 
by patients with chronic obstructive pulmonary disease 
(COPD) and to assess their impact on health outcomes and 
behaviors. Methods: Two hundred and sixty-six primary care 
patients who participated in the ICE COLD ERIC cohort study 
were asked to document any stressful life events in the past 
3 years. We assessed the before-after (the event) changes for 
symptoms of depression and anxiety, health status, dys-
pnea-related quality of life, exacerbations, cigarette use, and 
physical activity. We used linear regression analysis to esti-
mate the crude and adjusted magnitude of the before-after 
changes. Results: About 41% (110/266) of patients reported 
the experience of any stressful life events and “death of rela-
tives/important persons” was most common (31%). After ac-
counting for age, sex, living status, lung function, and anxi-
ety/depression status at baseline, experiencing any stressful 
life events was associated with a 0.9-point increase on the 
depression scale (95% CI 0.3 to 1.4), a 0.8-point increase on 
the anxiety scale (95% CI 0.3 to 1.3), and a 0.8-point decrease 
in the physical activity score (95% CI –1.6 to 0). Conclusions: 
Experiencing stressful life events was associated with a small 
to moderate increase in symptoms of depression and anxi-
ety in COPD, but no discernable effect was found for other 
physical outcomes. However, confirmation of these results 
in other COPD cohorts and identification of patients particu-
larly vulnerable to stressful life events are needed.
© 2017 S. Karger AG, Basel
Introduction
There is a general notion that psychological stress can 
cause mental and physical health problems [1, 2]. In epi-
demiological studies, one way to quantify stress is by 
counting the occurrence of stressful life events. Since the 
landmark study by Holmes and Rahe [3] on the assess-
ment of stressful life events, numerous studies have sug-
gested their relations with conditions, including psychi-
atric disorders, cardiovascular diseases, cancers, and au-
toimmune diseases [4–8]. Two main pathways have been 
proposed that can link stressful life events (or stress in 
general) with health problems. Stressful life events can 
induce physiological adjustment, such as an increase in 
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blood pressure and stress hormones or a decrease in im-
mune function. Stress might as well lead to behavioral 
changes, such as more use of tobacco or alcohol and less 
sleep or physical exercise [1, 2, 9]. Thus, stressful life 
events may increase the risk for many diseases.
In patients with chronic obstructive pulmonary dis-
ease (COPD), depression and anxiety have been widely 
investigated and were shown to increase patients’ risk of 
exacerbations or death [10, 11]. However, 1 potential 
cause of depression and anxiety, namely stressful life 
events, was rarely assessed in COPD cohorts. To the best 
of our knowledge, only in 1 cross-sectional study con-
ducted in Singapore [12], the investigators documented 
that experiencing stressful life events was associated with 
more depressive symptoms in COPD patients than in 
their non-COPD counterparts. There is, at present, a lack 
of evidence from longitudinal cohort studies regarding 
the type of stressful life events experienced by COPD pa-
tients, the impact of stressful life events on patient out-
comes, and the role that stressful life events play in COPD 
prognosis.
In this study, we explored the relationship between ex-
periencing stressful life events and several outcomes/be-
haviors, including depression, anxiety, dyspnea, health 
status, exacerbations, cigarette use, and physical activity 
in patients enrolled in the International Collaborative Ef-
fort on Chronic Obstructive Lung Disease: Exacerbation 
Risk Index Cohorts (ICE COLD ERIC) study. Our aims 
were, firstly, to describe the stressful life events reported 
by COPD patients and, secondly, to quantify the impact 
of stressful life events on patient outcomes/behaviors. 
Methods
Population
The study sample consisted of patients participating in the pro-
spective ICE COLD ERIC cohort study, for which the design paper 
and the baseline characteristics of participants have been pub-
lished previously [13, 14]. Briefly, patients with COPD aged 40 
years or older, in GOLD stage II–IV, and free of exacerbations for 
at least 4 weeks were recruited by their primary care physicians in 
the Netherlands or Switzerland from April 2008 to August 2009. 
The study exclusion criteria were being judged to have a life expec-
tancy of no more than 12 months and being diagnosed with de-
mentia, psychosis, or another psychiatric illness that may invali-
date the assessment of patient-reported outcomes. We followed 
the patients for up to 5 years and assessed at half-year intervals the 
patient-reported outcomes on health status, symptoms of anxiety 
and depression, levels of physical activity, and health-related qual-
ity of life. At the 3.5-year follow-up visit, we administered an ad-
ditional questionnaire on information on stressful life events that 
the patients had experienced in the past 3 years.
The ICE COLD ERIC study was approved by the medical ethics 
committees in Zurich (EK-1519) and Amsterdam (MEC-08-073). 
Each patient’s written consent to the study was obtained by the 
investigators.
Measures
Patients completed the Hospital Anxiety and Depression Scale 
(HADS), the Chronic Respiratory Disease Questionnaire (CRQ), 
and the feeling thermometer at baseline and at half-year intervals 
[13]. The HADS is a valid and reliable instrument to measure de-
pression and anxiety symptoms in patients with physical impair-
ment, with domain scores ranging from 0 (no depression or anxi-
ety at all) to 21 (very severe depression or anxiety) [15]. The CRQ 
is a valid and reliable instrument to measure disease-specific 
health-related quality of life in patients with COPD that includes 
domains of fatigue, dyspnea, emotional function, and mastery. 
Domain scores range from 0 (lowest level of quality of life) to 7 
(highest) [16]. The feeling thermometer is a modified visual ana-
logue scale with numerical values that range from 0 (worst imagin-
able health state) to 100 (best imaginable health state) to measure 
general health status in the past 7 days. It is part of the EuroQol 5 
and has been validated for COPD patients [17, 18]. Physical activ-
ity was assessed by the Longitudinal Ageing Study Amsterdam 
Physical Activity Questionnaire. As reported elsewhere [19], we 
generated a score ranging from 0 to 23 to indicate the level of phys-
ical activity at each assessment. 
To assess stressful life events, at the 3.5-year follow-up, trained 
study nurses asked the patients to recall whether they had experi-
enced in the past 3 years any life events that were so stressful that 
they seriously impacted their lives. Then they categorized these 
events into the following 9 categories: (1) death of relatives or im-
portant persons; (2) patient’s own disease; (3) disease of relatives 
or important persons; (4) relational problems with relatives or im-
portant persons; (5) financial worries; (6) unemployment or retire-
ment; (7) divorce, separation, or loss of friendship; (8) loss of pets, 
and (9) other. They also asked the patients to try to recall the date/
month/year of the occurrence of the events.
COPD exacerbations were assessed every 6 months based on pa-
tients’ interviews and then centrally adjudicated by an expert panel 
who had access to patient charts and study case report forms, using 
the definition of exacerbations reported in the design paper [13].
Statistical Analysis 
For each patient who had experienced at least 1 stressful life 
event, we computed the average of the HADS depression/anxiety 
scores, dyspnea-related quality of life scores, health status scores, 
physical activity scores, numbers of cigarettes smoked, and inci-
dence rate of exacerbations (per person-year) that were measured 
before the occurrence of the first stressful life event (“before peri-
od”) and after the first stressful life event (“after period”). In order 
to make comparisons, for each patient who had not experienced any 
stressful life events, we computed the average of scores/numbers or 
the incidence rate before visit 4 (“before period”) and from visit 4 
onwards (“after period”), because the median time of occurrence of 
stressful life events among those who had them was between visit 3 
and 4. We computed the difference between the 2 periods and used 
it as the dependent variable (before-after change) to represent the 
impact of stressful life events on health outcomes/behaviors.
We performed a linear regression analysis to assess if there was 
a difference between those who had any stressful life events and 
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those who did not, and we adjusted for sex, age (continuous), liv-
ing status (alone or not), and lung function (forced expiratory vol-
ume in 1 s). For the adjusted analysis of depression, we excluded 
patients who had clinically important depression symptoms 
(HADS score ≥11) at baseline, and, similarly, for the adjusted anal-
ysis of anxiety, we excluded patients who had clinically important 
anxiety symptoms (HADS score ≥11) at baseline. For other out-
comes, such patients were not excluded; instead, we adjusted for 
baseline clinically important depression/anxiety status (yes vs. no) 
in the regression models. Next, interaction terms of stressful life 
events with the other variables were added to the models to assess 
if any subgroups of patients were more vulnerable to the impact of 
stressful life events. All analyses were done using Stata, version 13 
(StataCorp LP, College Station, TX, USA).
Results
The ICE COLD ERIC study recruited 409 patients, 
and our sample included 266 patients who remained in 
the study (not dead or lost to follow-up) at the 3.5-year 
visit and completed the assessment of stressful life events. 
Table 1. Baseline characteristics of patients, stratified by patients’ reporting of stressful life events
Characteristics Total Any stressful life event reported
yes no
Patients, n 266 110 156
Sex, n (%)
Male 154 (58) 59 (54) 95 (61)
Female 112 (42) 51 (46) 61 (39)
Nationality, n (%)
Switzerland 122 (46) 49 (45) 73 (47)
The Netherlands 144 (54) 61 (55) 83 (53)
Mean age (SD), years 66.0 (9.4) 64.7 (9.6) 66.9 (9.2)
Mean BMI (SD) 26.4 (5.0) 26.6 (5.2) 26.3 (4.9)
Highest education, n (%)
Primary school 45 (17) 19 (17) 26 (17)
Secondary school 147 (55) 60 (55) 87 (56)
Intermediate vocational 44 (17) 18 (16) 26 (17)
Higher vocational/university 26 (10) 12 (11) 14 (9)
Profession, n (%)
Working or housewife 75 (28) 40 (36) 35 (22)
Retired 157 (59) 55 (50) 102 (65)
Disabled or unemployed 34 (13) 15 (14) 19 (12)
Living situation, n (%)
Alone 181 (68) 74 (67) 107 (69)
With partner or children 83 (31) 36 (33) 47 (30)
Mean smoking pack-years (SD) 44.3 (27.7) 44.2 (25.8) 44.4 (29.1)
Mean FEV1 (SD), % of predicted 56.9 (16.6) 57.0 (16.7) 56.9 (16.6)
Exacerbations in the previous year, n (%)
None 190 (71) 76 (69) 114 (73)
≥1 76 (29) 34 (31) 42 (27)
Mean CRQ dyspnea scores (SD) 4.9 (1.5) 4.6 (1.5) 5.1 (1.5)
Mean feeling thermometer scores (SD) 69.9 (15.3) 67.4 (15.7) 71.6 (14.8)
Mean HADS scores (SD) 
Depression 4.3 (3.6) 4.8 (3.9) 3.9 (3.4)
Anxiety 4.8 (4.2) 5.6 (4.6) 4.2 (3.8)
Medication use, n (%)
Depression 30 (11) 17 (15) 13 (8)
Anxiety 28 (11) 21 (19) 7 (4)
Inhaled corticosteroids 156 (59) 65 (59) 91 (58)
Long-acting β-agonists 152 (57) 59 (54) 93 (60)
BMI, body mass index; CRQ, Chronic Respiratory Disease Questionnaire; FEV1, forced expiratory volume in 
1 s; HADS, Hospital Anxiety and Depression Scale; SD, standard deviation.
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The study flow chart can be found in the online supple-
mentary materials (for all online suppl. material, see 
www.karger.com/doi/10.1159/000481714), and patients’ 
characteristics at baseline are shown in Table 1. Forty-
one percent (110/266) of the patients reported having ex-
perienced any stressful life events. Those who had expe-
rienced stressful life events were younger and less likely 
to be retired than those who had not experienced stress-
ful life events. Another noticeable difference was that 
those who had experienced stressful life events ascribed 
lower scores to their dyspnea-related quality of life and 
health status and reported more symptoms of depression 
and anxiety at study baseline. More of these patients were 
also taking depression and anxiety medications. The 
study sample included slightly more males (154/266, 
58%). 
One hundred and fifty-six (59%) patients reported 
not having experienced any stressful life events, 82 (31%) 
reported 1, 21 (8%) reported 2, and 7 (3%) reported 3 
events. The most commonly reported event by patients 
was “death of relatives/important persons,” followed by 
“patient’s own disease” and “disease of relatives/impor-
tant persons” (see Table 2, also presenting the number 
of patients who rated each event as “extremely stress-
ful”). 
The median time at which the patients reported having 
experienced the first event was between visit 3 (1.5-year 
follow-up visit) and 4 (2-year follow-up visit); the 25th 
percentile was between visit 1 (0.5-year follow-up visit) 
and 2 (1-year follow-up visit); the 75th percentile was be-
tween visit 5 (2.5-year follow-up visit) and 6 (3-year fol-
low-up visit). In 18 patients, the dates of all their reported 
stressful life events were before study baseline. These pa-
tients were counted as having “no stressful life events” in 
the analysis assessing the impact of stressful life events on 
patient outcomes since all outcome data were collected 
from baseline to the 3.5-year visit.
Table 3 summarizes the results that assessed the im-
pact of stressful life events on health outcomes/behaviors. 
The within-patient comparison for patients who had 
stressful life events suggests that, over time, these pa-
tients’ symptoms of depression increased and their dys-
pnea-related quality of life and health status decreased. 
The numbers of cigarettes smoked per day and their levels 
of physical activity decreased. In the multivariable linear 
regression analysis of the before-after change, we found 
that comparing those who reported any stressful life 
events with those who reported none, those reporting 
stressful life events had a greater increase in depression 
symptoms (coefficient 0.9; 95% confidence interval [CI] 
0.3 to 1.4) and a greater increase in anxiety symptoms 
(coefficient 0.8; 95% CI 0.3 to 1.3). 
To aid in interpretation, we defined “responders with 
depression/anxiety symptoms” to be patients who had a 
1.5-unit increase on the HADS depression/anxiety sub-
scale (minimal important difference [20]), comparing the 
“after period” with the “before period.” We found that 
among those who reported stressful life events, 38% 
(35/91) were responders with depression symptoms, 
while 25% (44/174) among those who reported no stress-
ful life events were responders with depression symptoms 
(χ2 statistic = 4.96, p value = 0.026). For anxiety symp-
toms, 30% (27/91) among those who reported stressful 
life events were responders with anxiety symptoms, and 
13% (22/174) among those who reported no stressful life 
events were responders with anxiety symptoms (χ2 statis-
tic = 11.49, p value = 0.001). Stressful life events were as-
sociated with more responders. 
Table 2. Categories of reported stressful life events
Events reporteda, 
N/145, %
Events rated as “extremely
stressful,” n/N, %
Death of relatives/important persons 45 (31) 11 (24)
Patient’s own disease 30 (21) 5 (17)
Disease of relatives/important persons 28 (19) 11 (39)
Relational problems with relatives/important persons 15 (10) 3 (20)
Financial worries 10 (7) 4 (40)
Unemployment/retirement 5 (3) 1 (20)
Divorce/separation/loss of friendship 5 (3) 2 (40)
Loss of pets 3 (2) 2 (67)
Other 4 (3) 0 (0)
a Total number of events = 145.
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Regarding health behaviors, patients who reported any 
stressful life events had a larger decrease in physical activ-
ity (coefficient –0.8; 95% CI –1.6 to 0) than those who 
reported none, while no difference was found for ciga-
rette use.
In the online supplementary materials, we reported 
the results of the multivariable linear regression analyses 
where we added interaction terms of stressful life events 
with each of the following variables: sex, age, living status, 
lung function, and baseline depression/anxiety status. 
There was no indication of any interactions for any of the 
outcomes/behaviors.
Discussion
In our study, we found that almost half of the COPD 
patients reported to have experienced events that were so 
stressful that they seriously impacted their lives. Our 
analyses suggest that experiencing stressful life events is 
Table 3. Summary of results assessing the impact of stressful life events on health outcomes and health behaviors
Health outcome/
health behavior
Any stressful life
events reported
(baseline to 3.5-year
follow-up visit)
N Average in
“before period,”
mean (95% CI)
Average in
“after period,”
mean (95% CI)
Average in “after period” – 
average in “before period”a
mean (95% CI) p value
Depression (HADS subscale) Yes 91 5.4 (4.6 to 6.2) 6.4 (5.6 to 7.3) 1.0 (0.5 to 1.6) <0.001
No 174 4.3 (3.8 to 4.8) 4.8 (4.3 to 5.4) 0.5 (0.3 to 0.8) <0.001
Difference (yes vs. no) 0.5 (0 to 1.1) 0.07
Adjusted difference (yes vs. no)b 0.9 (0.3 to 1.4) 0.003
Anxiety (HADS subscale) Yes 91 5.9 (4.9 to 6.9) 6.2 (5.2 to 7.1) 0.3 (–0.3 to 0.9) 0.35
No 174 4.5 (4.0 to 5.0) 4.4 (3.9 to 4.9) –0.1 (–0.3 to 0.2) 0.51
Difference (yes vs. no) 0.4 (–0.2 to 0.9) 0.19
Adjusted difference (yes vs. no)b 0.8 (0.3 to 1.3) 0.004
Dyspnea (CRQ subscale) Yes 92 4.5 (4.2 to 4.8) 4.4 (4.1 to 4.7) –0.2 (–0.3 to 0) 0.06
No 174 5.0 (4.8 to 5.2) 4.8 (4.6 to 5.0) –0.2 (–0.3 to –0.1) <0.001
Difference (yes vs. no) 0.1 (–0.1 to 0.3) 0.55
Adjusted difference (yes vs. no)c 0 (–0.2 to 0.2) 0.67
Health status (feeling thermometer) Yes 91 67.0 (64.3 to 69.7) 63.6 (60.9 to 66.3) –3.4 (–5.2 to –1.6) <0.001
No 174 70.4 (68.5 to 72.4) 67.7 (65.6 to 69.8) –2.7 (–3.9 to –1.5) <0.001
Difference (yes vs. no) –0.7 (–2.8 to 1.4) 0.53
Adjusted difference (yes vs. no)c –0.9 (–3.1 to 1.2) 0.39
COPD exacerbations Yes 92 0.7 (0.4 to 0.9) 0.6 (0.4 to 0.8) –0.1 (–0.3 to 0.2) 0.67
(incidence rate per person-year) No 174 0.5 (0.4 to 0.6) 0.5 (0.4 to 0.6) 0 (0 to 0.2) 0.43
Difference (yes vs. no) –0.1 (–0.3 to 0.1) 0.41
Adjusted difference (yes vs. no)c –0.1 (–0.3 to 0.2) 0.68
Physical activity (LAPAQ score) Yes 92 12.7 (11.7 to 13.8) 11.1 (10.0 to 12.2) –1.7 (–2.3 to –1.0) <0.001
No 174 12.2 (11.5 to 13.0) 11.3 (10.5 to 12.1) –0.9 (–1.4 to –0.5) <0.001
Difference (yes vs. no) –0.7 (–1.5 to 0.1) 0.07
Adjusted difference (yes vs. no)c –0.8 (–1.6 to 0) 0.05
Cigarette use Yes 91 7.5 (5.1 to 10.0) 5.6 (3.6 to 7.7) –1.9 (–2.8 to –0.9) <0.001
(n smoked per day) No 172 5.7 (4.2 to 7.3) 4.7 (3.3 to 6.1) –1.0 (–1.6 to –0.4) <0.001
Difference (yes vs. no) –0.9 (–1.9 to 0.2) 0.12
Adjusted difference (yes vs. no)c –0.6 (–1.7 to 0.5) 0.27
CI, confidence interval; COPD, chronic obstructive pulmonary disease; CRQ, Chronic Respiratory Disease Questionnaire; HADS, Hospital Anxiety and 
Depression Scale; LAPAQ, Longitudinal Aging Study Amsterdam Physical Activity Questionnaire. a For patients who had any stressful life event, “before 
period” is the time period before the first event and “after period” is the time period after the first event. For patients who had no stressful life event, “before 
period” is the time period before visit 4 and “after period” is the time period from visit 4 onwards. b We excluded patients who had baseline clinically important 
depression (for depression outcome) or anxiety (for anxiety outcome) and adjusted for age, sex, living status, and lung function in the regression analysis. 
c We adjusted for age, sex, living status, lung function, and depression/anxiety status at baseline in the regression analysis.
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associated with increased future symptoms of depression 
and anxiety, while no effect of stressful life events on oth-
er physical outcomes, including dyspnea, health status, 
and COPD exacerbations, was identified. We also found 
that stressful life events may be associated with a future 
decrease in physical activity. 
The 3 most commonly reported stressful life events by 
our study participants were “death of relatives/important 
persons” (31%), “patient’s own disease” (21%), and “dis-
ease of relatives/important persons” (19%), accounting 
for more than 70% of all events. The frequency of disease-
related events agrees with previous studies on stressful life 
events done in elderly populations, where health-related 
events were found to be the most frequent type of stress 
in older adults [21, 22]. Different events were perceived 
differently by our study participants. For example, among 
the 3 most frequently reported types of stressful life 
events, the proportion of patients who rated the event as 
“extremely stressful” was higher for “disease of relatives/
important persons” than for “death of relatives/impor-
tant persons” or “patient’s own disease.” The reason why 
“disease of relatives/important persons” was perceived as 
a more stressful event may be that the informal care given 
to those getting sick can be a substantial burden to most 
caregivers. It would also be interesting to learn whether 
these health-related events are perceived differently from 
those events that are not health related (e.g., financial 
worries, unemployment, and divorce). However, due to 
the small numbers of these events reported in our study, 
we cannot make such comparisons. 
Patients who reported stressful life events differed from 
those who did not report any stressful life events at base-
line regarding the levels of symptoms of depression and 
anxiety, dyspnea-related quality of life, and health status. 
Given that our instrument to assess stressful life events 
relied on patients’ recall of experience in the past years, it 
is likely that patients who were more depressed/anxious, 
had more severe dyspnea, and rated their health status as 
lower at baseline had a higher chance of remembering or 
reporting stressful life events. Also, such patients might be 
more prone to perceive an event as being “stressful,” or 
they might be less resilient to the same event than patients 
who were less depressed/anxious, had less severe dyspnea, 
and rated their health status as higher at baseline [6, 23]. 
Furthermore, there can be some strong confounding fac-
tors (e.g., individual personality traits) that are linked to 
patients’ symptoms, such as depression/anxiety, and at the 
same time affect their risk of experiencing stressful life 
events [6, 23]. Faced with such an imbalance in the base-
line characteristics, when doing the analysis to assess the 
impact of stressful life events on patient outcomes/behav-
iors, we took advantage of our longitudinal study design 
and within-patient comparison. 
According to the 2 main pathways proposed to link 
stressful life events with health problems, psychological 
stress may lead to physiological dysregulation or to worse 
health behaviors, which in turn increase the risk for ad-
verse outcomes [9]. In our study, we computed the with-
in-patient before-after change of health outcomes and be-
haviors. We tried to examine whether this within-patient 
change was more pronounced in patients who reported 
having experienced any stressful life events. After ac-
counting for confounders, we observed that stressful life 
events were associated with more symptoms of depres-
sion and anxiety. There seemed to be an association of 
stressful life events with less physical activity, but no as-
sociation with cigarette use was found. On the other hand, 
our analysis of stressful life events and physical outcomes 
did not suggest an association with COPD exacerbations 
and dyspnea-related quality of life, and the finding of a 
change in health status had a high variance. Because our 
study sample size was relatively small and our time frame 
of follow-up after the event was relatively short, more rep-
lications of these analyses in other COPD cohorts are 
needed in the future to examine the impact of stressful life 
events on COPD prognosis. 
Our study has several limitations. First, the stressful 
life events were retrospectively assessed by asking the par-
ticipants to recall the experience and dates of stressful life 
events for the past 3 years. This perhaps posed some chal-
lenge to the participants of this age group. Our study de-
sign could have been improved if a shorter time frame 
had been chosen (e.g., 1 year) for patients to recall their 
experience of stressful life events and if we had assessed 
this factor repeatedly. However, most stressful life events 
are significant events in patients’ life, so they should have 
been easier for patients to remember. Second, symptoms 
of depression and anxiety were assessed by self-reported 
questionnaires. We need to bear in mind that these are 
not a formal diagnosis of depression and anxiety, which 
will require a clinical interviewer and information from 
medical records or other informants. Third, because as-
sessments of stressful life events and most outcomes were 
completed by patients alone, there is a risk that the differ-
ences observed in the current study were confounded in 
part by this dependency upon self-reporting.
Despite these limitations, we believe that the present 
study still makes a valuable contribution to the current 
knowledge on stressful life events in COPD patients and 
on the influence of stressful life events on COPD out-
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comes. With data from a longitudinal follow-up study, we 
were able to demonstrate that experience of stressful life 
events may affect mental health, including more symp-
toms of depression and anxiety in patients with COPD, 
while we did not obtain similar findings for other physical 
outcomes. Stressful life events may also lead to a decrease 
in physical activity. The importance of mental health sta-
tus for patients with COPD has been well recognized by 
the clinical community over the past few years. Finding 
effective ways to cope with the stress encountered by 
COPD patients can be one of the future steps to reduce 
their risk of developing depression and anxiety.
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